Patent · US Active

Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorder

US9408840B2 · kind B2 · utility

6Cited by
5References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 8, 2015
Grant dateAug 9, 2016
Priority date—
Expiry dateJan 8, 2035

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure is directed to compounds of the structure (X):CoreL-NHE)n  (X)wherein: wherein: wherein:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.